| LINE ITEM (USD / %) | FY 2025
FILED 2026-05-30 | FY 2024
FILED 2025-05-31 | FY 2023
FILED 2024-06-01 |
|---|---|---|---|
| Revenue (Total Sales) | $2.91B | $4.26B | $2.33B |
| YoY Revenue Growth % | -31.7% | +83.2% | — |
| Gross Profit | $672.0M | $1.85B | — |
| Gross Margin % | 23.1% | 43.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $350.2M | $1.54B | $312.5M |
| Operating Margin % | 12.0% | 36.1% | 13.4% |
| Net Income (GAAP) | $316.7M | $1.22B | $277.9M |
| EBITDA (Normalized) | $471.2M | $1.67B | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $479.8M | $1.22B | $451.4M |
| Capital Expenditures (CapEx) | $151.2M | $161.3M | — |
| Free Cash Flow (FCF) | $328.5M | $1.06B | $451.4M |
| FCF Margin % | 11.3% | 25.0% | 19.4% |
| Return on Invested Capital (ROIC %) | 11.9% | 63.7% | — |
| Cash & Short-Term Equivalents | $369.4M | $140.3M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $2.69B | $2.05B | — |